February 27, 2026February 27, 2026 Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% on 27 February after the company’s US subsidiary announced that it will launch sodium phosphates injection USP in single-dose vials containing 15 mM P/5 mL, 45 mM p/15…
September 5, 2025September 5, 2025 Shares of Glenmark Pharmaceuticals Ltd soared 3% on Friday, 4 September, after the company announced securing approval from DCGI. Glenmark Pharmaceuticals’ shares surged after the Drugs Controller General of India (DCGI) approved a Phase 3 clinical trial of Envafolimab, a new subcutaneous PD-L1 inhibitor,…
June 18, 2025June 18, 2025 Shares of Glenmark Pharmaceuticals Ltd were trading in the red and almost 1% lower on Wednesday, 18 June, after the US Food and Drug Administration (USFDA) issued Form 483 with five observations for the company’s plant in Monroe, North Carolina. The US drug agency…
April 7, 2025April 7, 2025 Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday, 7 April, in response to comments made by US President Donald Trump about the upcoming taxes on the pharmaceutical…
February 27, 2025February 27, 2025 Shares of Glenmark Pharmaceuticals Ltd were trading in the red and 1% lower on Thursday, 27 February, despite the company’s US-based subsidiary announcing launching its epinephrine injection USP, a medication used to treat severe allergic responses. An injection comprising 10 mg/10 mL (1 mg/mL)…